Noemi Muszbek <br/><br/>
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works